Singapore's stock market has seen net retail inflow of S$1.01 billion in the 2024-to-date. UOB (SGX:U11) has seen the most net selling by retail investors in the 2Q24 (to 13 June) at S$366 million. On the other hand, Singapore Airlines (SIA, SGX:C6L) and Keppel (SGX:BN4) have seen the most net retail inflow in 2Q24 (to 13 June) at S$129 million each.
The iEdge SG Advanced Manufacturing Index experienced a significant increase in trading turnover in May, surging one-third higher than activity in April, and marking the most active month for Index constituents since March 2023. Of the actively traded Index stocks, Yangzijiang Shipbuilding, Mermaid Maritime and Marco Polo Marine booked the highest net institutional inflow proportionate to market cap.
S-REITs have typically been sought for investability traits including yield and stability. However, tighter financial conditions and a fluid outlook for these conditions has provided more tradability to the Sector. The iEdge S-REIT Leaders Index has declined 12.3% in 2024-to-date. This has coincided with an outlook of tight financial conditions for longer, and expectations for the quantum of Fed Funds Rate cuts by end of 1H25 curtailed to ~50bps or 75bps, down from ~175bps.
On 27 May, the STI closed at 3,318.45, its highest close since August 2023. The overall Singapore stock market booked a moderate amount of S$300mil in net institutional inflow over the 6 weeks. Banks, Financial Services and the Real Estate Management and Development Sectors led net institutional inflow. Yoma Strategic booked the second highest net institutional inflow relative to market cap, after Samudera Shipping, while maritime-related stocks Yangzijiang Shipbuilding, Dyna-Mac, Marco Polo Marine made up the next three stocks in the ranking.
DBS, OCBC and UOB have booked S$500 million in combined net institutional inflow for the 2024 year through to 23 May. The trio also averaged 16% total returns for the period, bringing their average total returns since the end of 2019, to 67% and combined weight in the STI to 51%. OCBC also posted its highest ever close price on 23 May.
Top Glove, Medtecs International, UG HealthCare and Riverstone have averaged 24% returns in the month-to-date, partially attributed to the Biden administration announcing higher tariff rates for certain imports from China including PPE items such as respirators and face masks, in addition to rubber medical and surgical gloves.
Five constituents of iEdge SG Advanced Manufacturing Index that have ranked among the most traded within the Index over the 20 weeks, while also seeing more than 50% increases in their average daily turnover compared to the full 2023 year, included Dyna-Mac, Riverstone, Food Empire, Aztech Global and Beng Kuang Marine.
Among the 50 most traded stocks of the iEdge SG Advanced Manufacturing Index this year, Global Invacom, Broadway Industrial, Willis-Array, Riverstone, Beng Kuang Marine and Mermaid Maritime chalk up the biggest surges in trading activity, compared to respective levels for the full 2023 year.
The quarterly review of the Straits Times Index (STI) in March leads to the inclusion of Frasers Centrepoint Trust (FCT) in the index, effective as of March 18, 2024. The number of retail malls in the portfolio of Frasers Centrepoint Trust has tripled since it listed in July 2006 with an initial unit price of S$1.03. It's unit price ended 12 March at S$2.19, and according to Bloomberg it has paid more than S$1.80 per unit in distributions since IPO, bringing its annualised total return since listing to 10.3%.
The STI Banks DBS, OCBC & UOB have proposed to pay final dividends (subject to shareholder approval) that take the 2023 total combined dividend amounts for the trio to S$11.5 billion. Based on end of FY23 share prices, this generated a 6.0% average dividend yield.
These articles are provided by SGX My Gateway.
SGX's investor education portal with market, product and investment information and events. Sign up now at sgx.com/mygateway to receive our investment updates and economic calendar.
These articles are not intended for distribution to, or for use by or to be acted on by any person or entity located in any jurisdiction where such distribution, use or action would be contrary to applicable laws or regulations or would subject Singapore Exchange Limited (“SGX”) to any registration or licensing requirement. This document is not an offer or solicitation to buy or sell, nor financial advice or recommendation for any investment product. This document is for general circulation only. It does not address the specific investment objectives, financial situation or particular needs of any person. Advice should be sought from a financial adviser regarding the suitability of any investment product before investing or adopting any investment strategies. Use of and/or reliance on this document is entirely at the reader’s own risk. Further information on this investment product may be obtained from www.sgx.com. Investment products are subject to significant investment risks, including the possible loss of the principal amount invested. Past performance of investment products is not indicative of their future performance. Examples provided are for illustrative purposes only. While each of SGX and its affiliates (collectively, the “SGX Group Companies”) have taken reasonable care to ensure the accuracy and completeness of the information provided, each of the SGX Group Companies disclaims any and all guarantees, representations and warranties, expressed or implied, in relation to this document and shall not be responsible or liable (whether under contract, tort (including negligence) or otherwise) for any loss or damage of any kind (whether direct, indirect or consequential losses or other economic loss of any kind, including without limitation loss of profit, loss of reputation and loss of opportunity) suffered or incurred by any person due to any omission, error, inaccuracy, incompleteness, or otherwise, any reliance on such information, or arising from and/or in connection with this document. The information in this document may have been obtained via third party sources and which have not been independently verified by any SGX Group Company. No SGX Group Company endorses or shall be liable for the content of information provided by third parties. The SGX Group Companies may deal in investment products in the usual course of their business, and may be on the opposite side of any trades. SGX is an exempt financial adviser under the Financial Advisers Act (Cap. 110) of Singapore. The information in this document is subject to change without notice. This document shall not be reproduced, republished, uploaded, linked, posted, transmitted, adapted, copied, translated, modified, edited or otherwise displayed or distributed in any manner without SGX’s prior written consent.